ribavirin has been researched along with Shock, Septic in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Biliotti, E; De Angelis, M; Esvan, R; Franchi, C; Garbuglia, AR; Palazzo, D; Spaziante, M; Taliani, G; Volpicelli, L | 1 |
| Decaens, T; Larrat, S; Loyrion, E; Payen, JF; Pouzol, P; Trouve-Buisson, T | 1 |
2 other study(ies) available for ribavirin and Shock, Septic
| Article | Year |
|---|---|
Autochthonous acute hepatitis E: treatment with sofosbuvir and ribavirin.
Topics: Acute-On-Chronic Liver Failure; Biomarkers; Coinfection; Drug Therapy, Combination; Fatal Outcome; Hepatitis E; Humans; Liver Function Tests; Male; Middle Aged; Ribavirin; Shock, Septic; Sofosbuvir; Treatment Outcome; Viral Load | 2018 |
Hepatitis E Virus Infection after Platelet Transfusion in an Immunocompetent Trauma Patient.
Topics: Adult; Antibodies, Viral; Antiviral Agents; Blood Donors; Blood Platelets; Blood Transfusion; Cholecystitis, Acute; Hepatitis E; Hepatitis E virus; Humans; Male; Platelet Transfusion; Respiratory Distress Syndrome; Ribavirin; Ribs; Shock, Septic; Spleen; Splenectomy; Splenic Rupture | 2017 |